Categories: Research

Burchard joins discussion on race and ethnicity

Burchard participates in a panel and explains the differences between race and ethnicity and more with NPR’s Science Friday aired January 15, 2010.

Shoichet research one of top breakthroughs for 2009

Wired Science has cited a computational model developed in the UCSF School of Pharmacy under the direction of faculty member Brian Shoichet, PhD, and applied and tested by scientists at the University of North Carolina at Chapel Hill School of Medicine, as one

Wells uses small molecules to trigger cell death

Research directed by senior author James Wells, PhD, chair of the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, has opened the door to a new way of studying and better understanding the processes of cell death (apoptosis), blood clotting, and other biochemic

Method to predict polypharmacology developed in Shoichet Lab

A computational method developed in the UCSF School of Pharmacy under the direction of faculty member Brian Shoichet, PhD, has the potential to predict new target diseases for existing drugs as well as unexpected side effects of approved drugs.

UCSF innovation among top 10 for 2009

The Scientist has cited a UCSF innovation among its top 10 list of tools to hit the life sciences in 2009. In the spotlight is a paper that reveals how to import plant "light switches" into mammalian cells to control complex regulatory processes. The paper appeared in the October 15, 2009 issue of...

Craik to lead Takeda-sponsored research on antibodies

Takeda San Francisco, Inc., announced September 21, 2009 that it has entered into a sponsored collaboration with UCSF to support antibody-related research in the laboratory of Charles S.

Kroetz discusses pharmacogenomics on KQED Quest radio

UCSF researcher Deanna Kroetz, PhD, discusses the impact of genetic differences on how an individual responds to drugs in a KQED Quest radio interview that aired September 14, 2009.

Study identifies lack of information about HER2 testing practices

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of...

UCSF researchers join consortium to target cancer in new ways

Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.

Pages